Literature DB >> 25996608

Structural comparison of four different antibodies interacting with human papillomavirus 16 and mechanisms of neutralization.

Jian Guan1, Stephanie M Bywaters2, Sarah A Brendle2, Hyunwook Lee1, Robert E Ashley1, Alexander M Makhov3, James F Conway3, Neil D Christensen2, Susan Hafenstein4.   

Abstract

Cryo-electron microscopy (cryo-EM) was used to solve the structures of human papillomavirus type 16 (HPV16) complexed with fragments of antibody (Fab) from three different neutralizing monoclonals (mAbs): H16.1A, H16.14J, and H263.A2. The structure-function analysis revealed predominantly monovalent binding of each Fab with capsid interactions that involved multiple loops from symmetry related copies of the major capsid protein. The residues identified in each Fab-virus interface map to a conformational groove on the surface of the capsomer. In addition to the known involvement of the FG and HI loops, the DE loop was also found to constitute the core of each epitope. Surprisingly, the epitope mapping also identified minor contributions by EF and BC loops. Complementary immunological assays included mAb and Fab neutralization. The specific binding characteristics of mAbs correlated with different neutralizing behaviors in pre- and post-attachment neutralization assays.
Copyright © 2015 The Authors. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Conformation; Crosslinking; Cryo-EM; Epitope; HPV16; Human papillomavirus; Neutralization; Stabilization; Virus Fab complex; mAb

Mesh:

Substances:

Year:  2015        PMID: 25996608      PMCID: PMC4516578          DOI: 10.1016/j.virol.2015.04.016

Source DB:  PubMed          Journal:  Virology        ISSN: 0042-6822            Impact factor:   3.616


  55 in total

1.  Fitting atomic models into electron-microscopy maps.

Authors:  M G Rossmann
Journal:  Acta Crystallogr D Biol Crystallogr       Date:  2000-10

2.  Combining electron microscopic with x-ray crystallographic structures.

Authors:  M G Rossmann; R Bernal; S V Pletnev
Journal:  J Struct Biol       Date:  2001-12       Impact factor: 2.867

3.  Reactivity pattern of 92 monoclonal antibodies with 15 human papillomavirus types.

Authors:  Raeda Z Rizk; Neil D Christensen; Kristina M Michael; Martin Müller; Peter Sehr; Tim Waterboer; Michael Pawlita
Journal:  J Gen Virol       Date:  2008-01       Impact factor: 3.891

Review 4.  The evolving field of human papillomavirus receptor research: a review of binding and entry.

Authors:  Adam B Raff; Andrew W Woodham; Laura M Raff; Joseph G Skeate; Lisa Yan; Diane M Da Silva; Mario Schelhaas; W Martin Kast
Journal:  J Virol       Date:  2013-03-27       Impact factor: 5.103

5.  A monoclonal antibody against intact human papillomavirus type 16 capsids blocks the serological reactivity of most human sera.

Authors:  Z Wang; N Christensen; J T Schiller; J Dillner
Journal:  J Gen Virol       Date:  1997-09       Impact factor: 3.891

6.  Generation of HPV pseudovirions using transfection and their use in neutralization assays.

Authors:  Christopher B Buck; Diana V Pastrana; Douglas R Lowy; John T Schiller
Journal:  Methods Mol Med       Date:  2005

7.  Preclinical model to test human papillomavirus virus (HPV) capsid vaccines in vivo using infectious HPV/cottontail rabbit papillomavirus chimeric papillomavirus particles.

Authors:  Andres F Mejia; Timothy D Culp; Nancy M Cladel; Karla K Balogh; Lynn R Budgeon; Christopher B Buck; Neil D Christensen
Journal:  J Virol       Date:  2006-09-27       Impact factor: 5.103

8.  Hybrid papillomavirus L1 molecules assemble into virus-like particles that reconstitute conformational epitopes and induce neutralizing antibodies to distinct HPV types.

Authors:  N D Christensen; N M Cladel; C A Reed; L R Budgeon; M E Embers; D M Skulsky; W L McClements; S W Ludmerer; K U Jansen
Journal:  Virology       Date:  2001-12-20       Impact factor: 3.616

Review 9.  Concepts of papillomavirus entry into host cells.

Authors:  Patricia M Day; Mario Schelhaas
Journal:  Curr Opin Virol       Date:  2013-12-14       Impact factor: 7.090

10.  Disassembly and reassembly of human papillomavirus virus-like particles produces more virion-like antibody reactivity.

Authors:  Qinjian Zhao; Yorgo Modis; Katrina High; Victoria Towne; Yuan Meng; Yang Wang; Jaime Alexandroff; Martha Brown; Bridget Carragher; Clinton S Potter; Dicky Abraham; Dave Wohlpart; Mike Kosinski; Mike W Washabaugh; Robert D Sitrin
Journal:  Virol J       Date:  2012-02-22       Impact factor: 4.099

View more
  25 in total

1.  The C-Terminal Arm of the Human Papillomavirus Major Capsid Protein Is Immunogenic and Involved in Virus-Host Interaction.

Authors:  Zhihai Li; Xiaodong Yan; Hai Yu; Daning Wang; Shuo Song; Yunbing Li; Maozhou He; Qiyang Hong; Qingbing Zheng; Qinjian Zhao; Ying Gu; Jun Zhang; Mandy E W Janssen; Giovanni Cardone; Norman H Olson; Timothy S Baker; Shaowei Li; Ningshao Xia
Journal:  Structure       Date:  2016-06-07       Impact factor: 5.006

2.  Naturally Occurring Major and Minor Capsid Protein Variants of Human Papillomavirus 45 (HPV45): Differential Recognition by Cross-Neutralizing Antibodies Generated by HPV Vaccines.

Authors:  Anna Godi; Alessandra Facchetti; Sara L Bissett; Clementina Cocuzza; Elizabeth Miller; Simon Beddows
Journal:  J Virol       Date:  2015-12-30       Impact factor: 5.103

3.  Production and characterization of a novel HPV anti-L2 monoclonal antibody panel.

Authors:  S M Bywaters; S A Brendle; J Biryukov; J W Wang; J Walston; J Milici; R B Roden; C Meyers; N D Christensen
Journal:  Virology       Date:  2018-08-28       Impact factor: 3.616

4.  Human Papillomavirus (HPV) Entry Inhibitors.

Authors:  Yun Zhu
Journal:  Adv Exp Med Biol       Date:  2022       Impact factor: 2.622

5.  Epitope mapping of antibodies in C-reactive protein assay kits by hydrogen-deuterium exchange mass spectrometry explains differential results across kits.

Authors:  Haofeng Sun; Jianyi Liu; Peng Xiao; Yi Zhou; Hongmei Li; Min Shen; Keqi Sun; Xiaojian Wang; Min Zhou; Dewei Song
Journal:  Anal Bioanal Chem       Date:  2022-04-07       Impact factor: 4.142

6.  Human Papillomavirus Major Capsid Protein L1 Remains Associated with the Incoming Viral Genome throughout the Entry Process.

Authors:  Stephen DiGiuseppe; Malgorzata Bienkowska-Haba; Lucile G M Guion; Timothy R Keiffer; Martin Sapp
Journal:  J Virol       Date:  2017-07-27       Impact factor: 5.103

7.  The U4 Antibody Epitope on Human Papillomavirus 16 Identified by Cryo-electron Microscopy.

Authors:  Jian Guan; Stephanie M Bywaters; Sarah A Brendle; Hyunwook Lee; Robert E Ashley; Neil D Christensen; Susan Hafenstein
Journal:  J Virol       Date:  2015-09-23       Impact factor: 5.103

8.  Comprehensive Assessment of the Antigenic Impact of Human Papillomavirus Lineage Variation on Recognition by Neutralizing Monoclonal Antibodies Raised against Lineage A Major Capsid Proteins of Vaccine-Related Genotypes.

Authors:  Anna Godi; Dolcibella Boampong; Busayo Elegunde; Kavita Panwar; Maxime Fleury; Shaowei Li; Qinjian Zhao; Ningshao Xia; Neil D Christensen; Simon Beddows
Journal:  J Virol       Date:  2020-11-23       Impact factor: 5.103

9.  Cross-protection of the Bivalent Human Papillomavirus (HPV) Vaccine Against Variants of Genetically Related High-Risk HPV Infections.

Authors:  Ariana Harari; Zigui Chen; Ana Cecilia Rodríguez; Allan Hildesheim; Carolina Porras; Rolando Herrero; Sholom Wacholder; Orestis A Panagiotou; Brian Befano; Robert D Burk; Mark Schiffman
Journal:  J Infect Dis       Date:  2015-10-30       Impact factor: 5.226

10.  Contribution of Surface-Exposed Loops on the HPV16 Capsid to Antigenic Domains Recognized by Vaccine or Natural Infection Induced Neutralizing Antibodies.

Authors:  Anna Godi; Stuti Vaghadia; Clementina Cocuzza; Elizabeth Miller; Simon Beddows
Journal:  Microbiol Spectr       Date:  2022-04-27
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.